Contributors

The people behind the genomic revolution

The Genomic Power Shift brings together interviews and perspectives from innovators, researchers and entrepreneurs who have helped lead this transformation. Their work has shaped the world we inhabit. Their next decisions will help shape the world we inherit.

These conversations go beyond the breakthroughs. They explore the convictions, unexpected turns and difficult choices behind them: what it takes to turn discovery into change, what progress makes possible, and what responsibility comes with the ability to rewrite life.

Together, these voices offer an inside view of a revolution still unfolding—from the pioneers who laid its foundations to the leaders shaping and creating its next frontiers—and all of our futures.

Meet the contributors

Hans Clevers

Professor

Hans Clevers

Hans Clevers is a Dutch stem cell biologist whose work has helped reveal how adult tissues regenerate and how cancer emerges from disrupted developmental programs. As a leader at the interface of molecular biology and translational medicine, he has shaped modern approaches to precision oncology and regenerative medicine. He is talking to us about the ethical considerations around the future use of organoids.

Carina Schlebusch

Professor

Carina Schlebusch

Carina Schlebusch is a leading evolutionary geneticist whose research traces how ancient human populations moved, mixed and adapted across Africa. Her work brings together population genomics, archaeology and anthropology to challenge assumptions about human history and illuminate the deep roots of genetic diversity. She is talking to us about how the future human genomic profile will be affected by reproductive support.

Portrait of Dr. Dimitris Polychronopoulos

AI Associate Director

Dimitris Polychronopoulos

Dimitris Polychronopoulos is a computational biologist working at the intersection of genomics, AI and drug discovery. His work spans large-scale genomic studies and AI-driven drug discovery, including cancer research at AstraZeneca. He is telling us about his experience of participating in the pioneering Generation Study, one of the world’s first and largest newborn genomic screening studies.

Future contributor placeholder

Coming soon

More voices

Additional contributors will be added as the project expands, each bringing a distinct lens on the science, ethics and human stakes of the genomic era.

Do you want your name here?

If you have a perspective or experience to contribute to the book, I would love to hear from you.